Grace Y. Lam

2.8k total citations
55 papers, 1.7k citations indexed

About

Grace Y. Lam is a scholar working on Pulmonary and Respiratory Medicine, Neurology and Clinical Psychology. According to data from OpenAlex, Grace Y. Lam has authored 55 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 15 papers in Neurology and 7 papers in Clinical Psychology. Recurrent topics in Grace Y. Lam's work include Long-Term Effects of COVID-19 (15 papers), Cystic Fibrosis Research Advances (14 papers) and COVID-19 and Mental Health (7 papers). Grace Y. Lam is often cited by papers focused on Long-Term Effects of COVID-19 (15 papers), Cystic Fibrosis Research Advances (14 papers) and COVID-19 and Mental Health (7 papers). Grace Y. Lam collaborates with scholars based in Canada, United States and United Kingdom. Grace Y. Lam's co-authors include John H. Brumell, Ju Huang, Sergio Grinstein, Michael Glogauer, Benjamin E. Steinberg, Marco Magalhaes, Mary C. Dinauer, Veronica Canadien, Darren E. Higgins and Aleixo M. Muise and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and PLoS ONE.

In The Last Decade

Grace Y. Lam

51 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grace Y. Lam Canada 18 559 471 421 207 193 55 1.7k
Jialin Liu China 26 420 0.8× 551 1.2× 310 0.7× 191 0.9× 102 0.5× 116 2.1k
Shuichi Miyazaki Japan 23 368 0.7× 519 1.1× 404 1.0× 100 0.5× 102 0.5× 92 1.6k
Yan Huang China 23 561 1.0× 672 1.4× 561 1.3× 96 0.5× 64 0.3× 123 2.2k
Zhuang‐Gui Chen China 25 149 0.3× 483 1.0× 519 1.2× 204 1.0× 161 0.8× 79 1.6k
Silvia M. Uriarte United States 28 441 0.8× 628 1.3× 880 2.1× 195 0.9× 41 0.2× 76 2.2k
Anirban Banerjee United States 21 454 0.8× 394 0.8× 215 0.5× 95 0.5× 68 0.4× 44 1.6k
Bruce A. Davidson United States 31 526 0.9× 564 1.2× 483 1.1× 813 3.9× 221 1.1× 92 2.6k
Elizabeth A. Mann United States 29 432 0.8× 812 1.7× 274 0.7× 186 0.9× 261 1.4× 63 2.4k
Jiali Xu China 26 235 0.4× 974 2.1× 284 0.7× 282 1.4× 42 0.2× 157 2.1k
Torsten Matthias Israel 27 566 1.0× 598 1.3× 510 1.2× 116 0.6× 25 0.1× 85 2.7k

Countries citing papers authored by Grace Y. Lam

Since Specialization
Citations

This map shows the geographic impact of Grace Y. Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grace Y. Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grace Y. Lam more than expected).

Fields of papers citing papers by Grace Y. Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grace Y. Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grace Y. Lam. The network helps show where Grace Y. Lam may publish in the future.

Co-authorship network of co-authors of Grace Y. Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Grace Y. Lam. A scholar is included among the top collaborators of Grace Y. Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grace Y. Lam. Grace Y. Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Estey, Mathew P., Heather Sharpe, Daniel R. Beriault, et al.. (2025). Time to replace the oral glucose tolerance test for cystic fibrosis related diabetes first-step screening? Establishing glycemic tools relevant to cystic fibrosis. Annals of Medicine. 57(1). 2514787–2514787.
2.
3.
Gershon, Andrea S., Daisy Fung, & Grace Y. Lam. (2025). Diagnosing Respiratory Long COVID. CHEST Journal. 168(4). 874–879.
4.
Godziuk, Kristine, Richard B. Thompson, Catherine B. Chan, et al.. (2024). Protocol for a pilot study: Feasibility of a web-based platform to improve nutrition, mindfulness, and physical function in people living with Post COVID-19 condition (BLEND). Methods. 231. 186–194. 1 indexed citations
5.
Lam, Grace Y., Paul E. Ronksley, Jeffrey A. Bakal, et al.. (2024). Impact of COVID-19 Pandemic on Chronic Obstructive Pulmonary Disease Healthcare Use, Exacerbations, and Mortality: A Population Study. Annals of the American Thoracic Society. 21(9). 1281–1288. 3 indexed citations
6.
Klionsky, Yael, et al.. (2024). POS0239 ACHIEVEMENT OF “GOUT REMISSION” DURING INTENSIVE URATE-LOWERING OVER 52 WEEKS OF PEGLOTICASE THERAPY. Annals of the Rheumatic Diseases. 83. 405–405.
7.
Potter, Kathryn J., Adèle Coriati, Larry C. Lands, et al.. (2023). Canadian Cystic Fibrosis–related Diabetes Clinical Practice Survey: Analysis of Current Practices and Gaps in Clinical Care. Canadian Journal of Diabetes. 47(3). 263–271.e1. 5 indexed citations
8.
Lam, Grace Y., Ronald W. Damant, Giovanni Ferrara, et al.. (2023). Characterizing long-COVID brain fog: a retrospective cohort study. Journal of Neurology. 270(10). 4640–4646. 10 indexed citations
9.
Miciak, Maxi, Pam Hung, Shu‐Ping Chen, et al.. (2023). “None of us are lying”: an interpretive description of the search for legitimacy and the journey to access quality health services by individuals living with Long COVID. BMC Health Services Research. 23(1). 1396–1396. 21 indexed citations
10.
Prentice, Bernadette, et al.. (2022). Cystic fibrosis related diabetes (CFRD) in the era of modulators: A scoping review. Paediatric Respiratory Reviews. 46. 23–29. 11 indexed citations
11.
Soril, Lesley, Ronald W. Damant, Grace Y. Lam, et al.. (2022). The effectiveness of pulmonary rehabilitation for Post-COVID symptoms: A rapid review of the literature. Respiratory Medicine. 195. 106782–106782. 38 indexed citations
12.
Estey, Mathew P., Tanya N. Nelson, Michelle Parker, et al.. (2021). Is the diagnostic rate for the common subtypes of A1AT deficiency consistent across two Canadian Provinces?. Clinical Biochemistry. 95. 84–88. 1 indexed citations
13.
Jung, David H., et al.. (2020). Circulating CRP and calprotectin to diagnose CF pulmonary exacerbations. Journal of Cystic Fibrosis. 20(1). 46–49. 9 indexed citations
14.
15.
Lam, Grace Y., et al.. (2020). Sex disparities in cystic fibrosis: review on the effect of female sex hormones on lung pathophysiology and outcomes. ERJ Open Research. 7(1). 475–2020. 30 indexed citations
16.
Lam, Grace Y., et al.. (2019). The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis. Annals of the American Thoracic Society. 17(2). 147–154. 72 indexed citations
17.
Lewis, Kevin C., Grace Y. Lam, Daniel J. Mazur, et al.. (2018). Inconsistent Adoption of World Health Organization V (2010) Semen Analysis Reference Ranges in the United States Eight Years After Publication. Urology. 126. 96–101. 1 indexed citations
18.
Lam, Grace Y., Karina Rodríguez-Capote, Trefor Higgins, et al.. (2017). The use of fructosamine in cystic fibrosis-related diabetes (CFRD) screening. Journal of Cystic Fibrosis. 17(1). 121–124. 12 indexed citations
19.
Huang, Ju, Veronica Canadien, Grace Y. Lam, et al.. (2009). Activation of antibacterial autophagy by NADPH oxidases. Proceedings of the National Academy of Sciences. 106(15). 6226–6231. 439 indexed citations
20.
Lam, Grace Y., et al.. (2002). Leydig cell tumour – A rare testicular tumour. International Urology and Nephrology. 33(1). 103–105. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jialin Liu Breakdown of academic impact, for papers by Shuichi Miyazaki Breakdown of academic impact, for papers by Yan Huang Breakdown of academic impact, for papers by Zhuang‐Gui Chen Breakdown of academic impact, for papers by Silvia M. Uriarte Breakdown of academic impact, for papers by Anirban Banerjee Breakdown of academic impact, for papers by Bruce A. Davidson Breakdown of academic impact, for papers by Elizabeth A. Mann Breakdown of academic impact, for papers by Jiali Xu Breakdown of academic impact, for papers by Torsten Matthias
Rankless by CCL
2026